Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Early cytokine signatures of ischemia/reperfusion injury in human orthotopic liver transplantation.

Sosa RA, Zarrinpar A, Rossetti M, Lassman CR, Naini BV, Datta N, Rao P, Harre N, Zheng Y, Spreafico R, Hoffmann A, Busuttil RW, Gjertson DW, Zhai Y, Kupiec-Weglinski JW, Reed EF.

JCI Insight. 2016 Dec 8;1(20):e89679.

2.

Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features.

Wood LD, Heaphy CM, Daniel HD, Naini BV, Lassman CR, Arroyo MR, Kamel IR, Cosgrove DP, Boitnott JK, Meeker AK, Torbenson MS.

Mod Pathol. 2013 Dec;26(12):1586-93. doi: 10.1038/modpathol.2013.68. Epub 2013 May 3.

3.

Interleukin-22: implications for liver ischemia-reperfusion injury.

Chestovich PJ, Uchida Y, Chang W, Ajalat M, Lassman C, Sabat R, Busuttil RW, Kupiec-Weglinski JW.

Transplantation. 2012 Mar 15;93(5):485-92. doi: 10.1097/TP.0b013e3182449136.

4.

Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liver.

Levy M, Trivedi A, Zhang J, Miles L, Mattis AN, Kim GE, Lassman C, Anders RA, Misdraji J, Yerian LM, Xu H, Dhall D, Wang HL.

Hum Pathol. 2012 May;43(5):695-701. doi: 10.1016/j.humpath.2011.06.016. Epub 2011 Sep 19.

5.

Apolipoprotein A1 and C-terminal fragment of α-1 antichymotrypsin are candidate plasma biomarkers associated with acute renal allograft rejection.

Ziegler ME, Chen T, LeBlanc JF, Wei X, Gjertson DW, Li KC, Khalighi MA, Lassman CR, Veale JL, Gritsch HA, Reed EF.

Transplantation. 2011 Aug 27;92(4):388-95. doi: 10.1097/TP.0b013e318225db6a.

6.

Type I interferon pathway mediates renal ischemia/reperfusion injury.

Freitas MC, Uchida Y, Lassman C, Danovitch GM, Busuttil RW, Kupiec-Weglinski JW.

Transplantation. 2011 Jul 27;92(2):131-8. doi: 10.1097/TP.0b013e318220586e.

7.

Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis.

Rajasekaran SA, Huynh TP, Wolle DG, Espineda CE, Inge LJ, Skay A, Lassman C, Nicholas SB, Harper JF, Reeves AE, Ahmed MM, Leatherman JM, Mullin JM, Rajasekaran AK.

Mol Cancer Ther. 2010 Jun;9(6):1515-24. doi: 10.1158/1535-7163.MCT-09-0832. Epub 2010 May 25.

8.

Tezosentan, a novel endothelin receptor antagonist, markedly reduces rat hepatic ischemia and reperfusion injury in three different models.

Farmer DG, Kaldas F, Anselmo D, Katori M, Shen XD, Lassman C, Kaldas M, Clozel M, Busuttil RW, Kupiec-Weglinski J.

Liver Transpl. 2008 Dec;14(12):1737-44. doi: 10.1002/lt.21621.

9.

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.

Duffy JP, Vardanian A, Benjamin E, Watson M, Farmer DG, Ghobrial RM, Lipshutz G, Yersiz H, Lu DS, Lassman C, Tong MJ, Hiatt JR, Busuttil RW.

Ann Surg. 2007 Sep;246(3):502-9; discussion 509-11.

10.

Type III mixed cryoglobulinemia and antiphospholipid syndrome in a patient with partial DiGeorge syndrome.

Chang AD, Tachdjian R, Gallagher K, McCurdy DK, Lassman C, Stiehm ER, Yadin O.

Clin Dev Immunol. 2006 Jun-Dec;13(2-4):261-4.

11.

A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.

Ghobrial RM, Steadman R, Gornbein J, Lassman C, Holt CD, Chen P, Farmer DG, Yersiz H, Danino N, Collisson E, Baquarizo A, Han SS, Saab S, Goldstein LI, Donovan JA, Esrason K, Busuttil RW.

Ann Surg. 2001 Sep;234(3):384-93; discussion 393-4.

12.

Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury.

Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD, Zhao D, Zaky J, Melinek J, Lassman CR, Kolls JK, Alam J, Ritter T, Volk HD, Farmer DG, Ghobrial RM, Busuttil RW, Kupiec-Weglinski JW.

J Clin Invest. 1999 Dec;104(11):1631-9.

Supplemental Content

Loading ...
Support Center